FUZIM-500 contains Cefuroxime Axetil 500 mg, a second-generation oral cephalosporin
antibiotic effective against a wide range of gram-positive and gram-negative bacterial infections.
It acts by inhibiting bacterial cell wall synthesis, leading to effective bactericidal action.

Key Benefits:
● Broad-spectrum antibacterial activity against respiratory, urinary, and skin infections
● High-dose formulation for moderate to severe infections
● Stable in the presence of β-lactamase-producing bacteria
● Well-absorbed orally with improved compliance in twice-daily dosing
● Proven safety and tolerability profile

Indications:
● Acute bacterial sinusitis
● Community-acquired pneumonia and bronchitis
● Uncomplicated urinary tract infections
● Skin and soft tissue infections
● Tonsillitis, pharyngitis, and otitis media